Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results

Go back to Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results

Merck (MRK) Tops Q4 EPS by 24c

February 3, 2022 6:32 AM EST

Merck (NYSE: MRK) reported Q4 EPS of $1.80, $0.24 better than the analyst estimate of $1.56. Revenue for the quarter came in at $13.5 billion versus the consensus estimate of $13.46 billion.

GUIDANCE:

Merck sees FY2022 EPS of $7.12-$7.27, versus the consensus of $7.29. Merck sees... More